We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,202.60
Bid: 1,202.40
Ask: 1,202.80
Change: -13.40 (-1.10%)
Spread: 0.40 (0.03%)
Open: 1,202.20
High: 1,236.80
Low: 1,201.20
Yest. Close: 1,216.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

MARKET PULSE-Amerisource, Affymax, Sarepta, BofA, Ebay, Lululemon

March 19 (Reuters) - Some U.S. stocks on the move on Tuesday: (For more market insights, including options activity, click on ; for The Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/faq23t) FUTURES GAIN BEFORE DATA

19 Mar 13 13:53

MARKET PULSE-Amerisource, Sarepta, BofA, Ebay, Lululemon, Juniper

March 19 (Reuters) - Some U.S. stocks to watch on Tuesday: (For more market insights, including options activity, click on ; for The Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/faq23t) FUTURES GAIN BEFORE DATA, F

19 Mar 13 13:21

MARKET PULSE-Sarepta, BofA, Ebay, Lululemon, Juniper

March 19 (Reuters) - Some U.S. stocks to watch on Tuesday: (For more market insights, including options activity, click on ; for The Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/faq23t) FUTURES GAIN BEFORE DATA, F

19 Mar 13 13:01

Germany fines consumer goods firms in information-sharing probe

FRANKFURT, March 18 (Reuters) - Germany's cartel office said it would fine a number of consumer goods companies 39 million euros ($51 million), including L'Oreal and Procter & Gamble in Germany, for taking part in anti-competitive sharing of information. The cartel office said the companies

18 Mar 13 19:12

GlaxoSmithKline boss says new drugs can be cheaper

* Improved R&D productivity can be passed on as lower prices * GSK CEO says $1 bln drug development cost a "myth" By Ben Hirschler LONDON, March 14 (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in researc

14 Mar 13 15:13

US CORP BONDS-IG MIDDAY: Healthy flow in primary market

By John Balassi March 13 (IFR) - The US high-grade primary market is seeing a healthy deal flow on Wednesday following consecutive issuance days topping US$5bn, with a large benchmark deal helping to drive supply. Although the credit indices have grinded to their best levels since the

13 Mar 13 16:09

UPDATE 1-Hypermarcas off to soft start in 2013-CEO

By Brad Haynes SAO PAULO, March 11 (Reuters) - Hypermarcas SA's chief executive said on Monday the Brazilian drugmaker has started the year with weaker sales than expected, but reaffirmed its target for operating profit this year. Strong pharmaceutical sales led to a better-than-expe

11 Mar 13 16:33

Monday broker round-up UPDATE

Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling. Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral. Anite Group: Invetsec downgrades from buy to hold with a target price of 157p. Aviva: Citigroup reduc

11 Mar 13 07:23

RPT-Narcolepsy link to Glaxo vaccine poses challenge for FDA

By Toni Clarke March 7 (Reuters) - Growing evidence of a link between GlaxoSmithKline Plc's pandemic flu vaccine and an increase in narcolepsy cases among children who received it in Europe, is giving pause to health regulators weighing approval of a similar vaccine in the United States.</p

8 Mar 13 12:31

Narcolepsy link to Glaxo vaccine poses challenge for FDA

By Toni Clarke March 7 (Reuters) - Growing evidence of a link between GlaxoSmithKline Plc's pandemic flu vaccine and an increase in narcolepsy cases among children who received it in Europe, is giving pause to health regulators weighing approval of a similar vaccine in the United States.</p

7 Mar 13 22:01

UPDATE 2-S.African drugmaker Aspen to step up Asian expansion

* Eyes expansion in Malaysia, Indonesia and Thailand * Unlikely to buy in Latin America due to high price tags * Headline earnings per share at 371 cents vs 316 cents By Tiisetso Motsoeneng JOHANNESBURG, March 7 (Reuters) - Africa's biggest generic drugs maker, Aspen Pharm

7 Mar 13 16:55

GlaxoSmithKiline seeks authorisation for type-2 diabetes treatment

FTSE-100 listed pharmaceutical giant GlaxoSmithKline (GSK) has submitted a marketing authorisation application (MAA) for its albiglutide treatment to the European Medicines Agency (EMA). The product is an investigational once-weekly treatment for adult patients with type-2 diabetes which is not ye

7 Mar 13 13:05

GSK files for European approval of diabetes drug albiglutide

LONDON, March 7 (Reuters) - Britain's biggest drugmaker GlaxoSmithKline said on Thursday it had filed for European approval of its new once-weekly diabetes drug albiglutide, as tries to gain a foothold in a crowded market. Albiglutide, used to treat type 2 diabetes, belongs to the same clas

7 Mar 13 12:03

London open: Fed comments provide support ahead of BoE, ECB

The FTSE 100 held on to recent gains on Thursday morning ahead of central-bank policy decisions in the UK and Europe, as comments from the Federal Reserve provided some support. According to the Fed's Beige Book released last night, the US economy expanded at a "modest to moderate pace" at the star

7 Mar 13 08:43

GlaxoSmithKline unveils positive data from HIV drug study

ViiV Healthcare, a global specialist HIV company set up by GlaxoSmithKline in 2009, has announced positive 24-week data from its Phase III Sailing study, which has investigated the effects of its dolutegravir treatment, a type of integrase inhibitor, in patients with HIV-1 who are failing on current

7 Mar 13 08:08

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.